Jeevan Scientific closes trading window ahead of Q2FY27 results

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Trading window closed from October 1, 2026
  • Closure lasts until 48 hours post-Q2FY27 results
  • Applies to designated persons and connected persons
  • Complies with SEBI insider trading regulations
powered bylight_fuzz_icon
52235801

*this image is generated using AI for illustrative purposes only.

Jeevan Scientific Technology Limited has closed its trading window for dealing in securities from October 1, 2026, until 48 hours after the declaration of financial results for the quarter ended September 30, 2026.

This action is taken pursuant to the company's Code of Conduct for Prevention of Insider Trading, adopted under the SEBI (Prohibition of Insider Trading) Regulations, 2015. The closure applies to all designated persons, their immediate relatives, and all connected persons covered under the code.

Regulatory Compliance Details

The company notified BSE Limited regarding the closure on September 29, 2026. The communication confirms that the trading window remains closed to prevent insider trading during the sensitive period leading up to the earnings announcement.

Parameter Detail
Trading Window Start October 1, 2026
Window Closure End 48 hours after Q2FY27 results declaration
Applicable Quarter Quarter ended September 30, 2026
Regulatory Basis SEBI (Prohibition of Insider Trading) Regulations, 2015

Board Meeting Schedule

The date of the Board meeting for declaring the financial results for the quarter ending September 30, 2026, will be intimated in due course. Until then, the restriction on trading remains in effect for all relevant parties associated with the company.

Historical Stock Returns for Jeevan Scientific Technology

1 Day5 Days1 Month6 Months1 Year5 Years
+4.99%+0.76%+10.73%+26.56%+131.43%-10.99%

How might the delayed announcement of the board meeting date impact investor sentiment and stock liquidity during the closed trading window?

What are the expected revenue and profit growth trajectories for Jeevan Scientific Technology Limited in Q2 FY27 compared to the previous quarter?

Will the upcoming financial results reveal any significant changes in the company's debt profile or working capital management strategies?

Jeevan Scientific Technology
View Company Insights
View All News
like17
dislike

Jeevan Scientific AGM passes all resolutions on director reappointments

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • All eight resolutions passed at Jeevan Scientific Technology Limited's 28th AGM held on September 25, 2026.
  • Promoters cast 4,590,385 votes in favor, while public non-institutional shareholders voted 579,032 shares.
  • Minor dissent of 902 votes recorded against specific director reappointments, representing under 0.16% of public votes.
  • Meeting attended by 82 members via video conferencing, supervised by scrutinizer Aakanksha Dubey & Co.
powered bylight_fuzz_icon
51865781

*this image is generated using AI for illustrative purposes only.

Jeevan Scientific Technology Limited concluded its 28th Annual General Meeting on September 25, 2026, with all eight proposed resolutions passing with the requisite majority. The meeting was conducted through Video Conferencing and Other Audio-Visual Means in compliance with regulatory guidelines.

Key Resolutions Passed

The shareholders approved the adoption of the standalone and consolidated audited financial statements for FY26. Additionally, the meeting addressed several governance matters, including the reappointment of directors retiring by rotation and the continuation of executive leadership beyond statutory age limits.

Resolution Type Outcome
Adoption of Financial Statements FY26 Ordinary Passed
Reappointment of Krishna Kishore Kuchipudi Ordinary Passed
Reappointment of Snigdha Mothukuri Ordinary Passed
Reappointment of Snigdha Mothukuri as WTD Special Passed
Continuation of Nageswar Rao Yarlagadda as WTD Special Passed
Reappointment of Nageswar Rao Yarlagadda as WTD Special Passed
Reappointment of Suryaprakasa Rao Bommisetti as ID Special Passed
Appointment of Kolli Srinivas Rao as ID Special Passed

Governance and Leadership Changes

The AGM ratified the reappointment of Snigdha Mothukuri and Nageswar Rao Yarlagadda as Whole Time Directors. A specific special resolution was passed to approve the continuation of Mr. Yarlagadda as Whole Time Director beyond the age of 70 years. The board also saw changes in its independent director composition with the reappointment of Suryaprakasa Rao Bommisetti and the appointment of Kolli Srinivas Rao.

Voting Participation Details

A total of 82 members attended the meeting through video conferencing, comprising 4 promoters and 78 public shareholders. The voting process was supervised by M/s. Aakanksha Dubey & Co., Practicing Company Secretaries, who served as the scrutinizer. The e-voting window was open from September 22 to September 24, 2026, prior to the live meeting.

What the Numbers Show

Voting results indicate strong promoter support, with promoters casting 4,590,385 votes in favor across all resolutions. Public non-institutional shareholders voted 579,032 shares, with a marginal dissent of 902 votes against certain director reappointments (Resolutions 2, 3, 4, 7, and 8), representing less than 0.16% of the public votes polled. Notably, Resolutions 1, 5, and 6 received 100% support from both promoter and public categories, suggesting minimal opposition from minority shareholders regarding the board's structural changes and financial approvals.

Historical Stock Returns for Jeevan Scientific Technology

1 Day5 Days1 Month6 Months1 Year5 Years
+4.99%+0.76%+10.73%+26.56%+131.43%-10.99%

How will the appointment of Kolli Srinivas Rao as an independent director influence Jeevan Scientific Technology's strategic direction and governance standards in the coming fiscal year?

What are the long-term succession planning implications for the company given the special resolution allowing Mr. Yarlagadda to continue as Whole Time Director beyond the statutory age limit?

In what ways might the approved FY26 financial statements impact the company's future capital allocation strategy or potential dividend distributions?

Jeevan Scientific Technology
View Company Insights
View All News
like20
dislike

More News on Jeevan Scientific Technology

1 Year Returns:+131.43%